Name | thrombin |
---|---|
Synonyms | Coagulation factor II; Coagulation factor II variant; F2; F2 protein; F2 protein precursor; Factor II; PT; Prothrombin… |
Name | ethylene oxide |
---|---|
CAS | oxirane |
PubMed | Abstract | RScore(About this table) | |
---|---|---|---|
12857094 | Pompe T, Zschoche S, Herold N, Salchert K, Gouzy MF, Sperling C, Werner C: Maleic anhydride copolymers--a versatile platform for molecular biosurface engineering. Biomacromolecules. 2003 Jul-Aug;4(4):1072-9. Examples concern the impact of the substrate-anchorage of fibronectin on the formation of cell-matrix adhesions, the orientation of endothelial cells according to lateral anti-adhesive micropatterns using grafted poly (ethylene oxide), and the spacer-dependent activity of immobilized synthetic thrombin inhibitors. |
31(0,1,1,1) | Details |
15143535 | Yu G, Ji J, Wang D, Feng L, Shen J: [Blood compatibility of two novel polyurethane coating materials] . Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004 Apr;21(2):184-7. Amphiphilic coupling-polymer of stearyl poly (ethylene oxide)-co-4, 4'-methylendiphenyl diisocyanate-co-stearyl poly (ethylene oxide), MSPEO, was specially designed as surface-modifying additives. Two kinds of static clotting time tests, plasma recalcification time (PRT) and prothrombin time (PT), as well as the static platelet adhesion experiment were carried out. |
1(0,0,0,1) | Details |
19449820 | Jung H, Kim JY, Kim Y, Tae G, Kim YH, Johannsmann D: QCM and AFM analysis of anticoagulant activities of sulfonated polymers against fibrin formation. Langmuir. 2009 Jun 16;25(12):7032-41. Four types of sulfonated polymers including sulfonated (S- monosulfonated poly (ethylene oxide) (PEO-SO (3)), disulfonated PEO (PEO-2SO (3)), and 4-arm sulfonated PEO (PEO-4SO (3)) were studied to compare with in the presence or in the absence of antithrombin III (AT). All the sulfonated polymers showed the -like activities to inhibit the function of thrombin for fibrin formation in the more or less extent while and PEO did not. |
1(0,0,0,1) | Details |